Abstract 4364295: Heart Rate Variability Metrics from Wearable Devices Predict Symptom Flares in Female Chronic Pelvic Pain Disorders

Background: Female chronic pelvic pain disorders (CPPD) are marked by unpredictable symptom flares, involving both pain and non-pain symptoms that affect the gastrointestinal (GI) and genitourinary (GU) systems. Management is challenging due to limited understanding of pathophysiology and lack of reliable predictors. Heart rate variability (HRV), the measure of small-time differences between heartbeats and an indicator of autonomic nervous system function, has shown promise as a digital biomarker for pain and inflammation. Research Question: This study evaluates whether real-time wearable and patient-tracked data can predict CPPD symptom flares. Methods: The final analytic sample comprised of 311,308 HRV measurements, characterized as RMSSD (root mean square of successive differences) and LF/HF (low frequency/high frequency), across 4,166 person-days from 87 females with CPPD in an observational study using an mHealth application (ehive iOS and android) and Fitbit tracker (model Inspire 3). The primary outcome was the “flare week” score, defined as a 7-day period with more days of disease-specific symptom flares than baseline. The daily “flare score” is the product of the number of CPPD-related pain and GI/GU symptoms with their intensity. Cosinor mixed-effects regression was applied to HRV circadian features: midline-estimating statistic of rhythm (MESOR), amplitude and acrophase. Covariates included age, body mass index (BMI), daily steps, sleep efficiency, and menstrual period. Participant ID and person-level amplitude and acrophase were included as random effects. Results: HRV circadian patterns significantly differed in the week prior to a flare week (Figure 1). RMSSD’s MESOR and amplitude decreased in the preceding week (Table 1), while the acrophase increased (all p<0.05). For LF/HF, the MESOR significantly decreased in a week preceding a flare. Menstrual period was positively associated with RMSSD, while menstrual period, daily step count, and sleep efficiency were inversely associated with LF/HF. Significant interactions for both metrics included obesity with amplitude, period with amplitude and steps with acrophase. There was significant variance in the HRV between-participants based on the significant random effects. Conclusions: We present initial evidence that HRV metrics can predict CPPD symptom fares via non-linear estimation, supporting a promising use of real-time mHealth and wearable data in the context of CPPDs.